Comparison of the Safety and Efficacy of Automated Annotation-Guided Radiofrequency Ablation and 2nd-Generation Cryoballoon Ablation in Paroxysmal Atrial Fibrillation.


Journal

Circulation journal : official journal of the Japanese Circulation Society
ISSN: 1347-4820
Titre abrégé: Circ J
Pays: Japan
ID NLM: 101137683

Informations de publication

Date de publication:
25 02 2019
Historique:
pubmed: 7 2 2019
medline: 31 3 2020
entrez: 7 2 2019
Statut: ppublish

Résumé

Automated ablation lesion annotation with optimal settings for parameters including contact force (CF) and catheter stability may be effective for achieving durable pulmonary vein isolation. Methods and Results: We retrospectively examined 131 consecutive patients who underwent initial catheter ablation (CA) for paroxysmal atrial fibrillation (PAF) by automatic annotation system (VISITAG module)-guided radiofrequency CA (RFCA) (n=61) and 2nd-generation cryoballoon ablation (CBA) (n=70) in terms of safety and long-term efficacy. The automatic annotation criteria for the RFCA group were as follows: catheter stability range of motion ≤1.5 mm, duration ≥5 s, and CF ≥5 g. We ablated for >20 s with a force-time integral >150 gs at each site, before moving to the next site. Each interlesion distance was <6 mm. Procedural complications were more frequent in the CBA group (1.6% vs. 10.0%, P=0.034). Across a median follow-up of 2.98 years, 88.5% and 70.0% of patients in the RFCA and CBA groups, respectively, were free from recurrence (log-rank test, P=0.0039). There was also a significant difference in favor of RFCA with respect to repeat ablations (3.3% vs. 24.3%, log-rank test, P=0.0003). RF ablation guided by an automated algorithm that includes CF and catheter stability parameters showed better long-term outcomes than CBA in the treatment of patients with PAF without increasing complications.

Sections du résumé

BACKGROUND
Automated ablation lesion annotation with optimal settings for parameters including contact force (CF) and catheter stability may be effective for achieving durable pulmonary vein isolation. Methods and Results: We retrospectively examined 131 consecutive patients who underwent initial catheter ablation (CA) for paroxysmal atrial fibrillation (PAF) by automatic annotation system (VISITAG module)-guided radiofrequency CA (RFCA) (n=61) and 2nd-generation cryoballoon ablation (CBA) (n=70) in terms of safety and long-term efficacy. The automatic annotation criteria for the RFCA group were as follows: catheter stability range of motion ≤1.5 mm, duration ≥5 s, and CF ≥5 g. We ablated for >20 s with a force-time integral >150 gs at each site, before moving to the next site. Each interlesion distance was <6 mm. Procedural complications were more frequent in the CBA group (1.6% vs. 10.0%, P=0.034). Across a median follow-up of 2.98 years, 88.5% and 70.0% of patients in the RFCA and CBA groups, respectively, were free from recurrence (log-rank test, P=0.0039). There was also a significant difference in favor of RFCA with respect to repeat ablations (3.3% vs. 24.3%, log-rank test, P=0.0003).
CONCLUSIONS
RF ablation guided by an automated algorithm that includes CF and catheter stability parameters showed better long-term outcomes than CBA in the treatment of patients with PAF without increasing complications.

Identifiants

pubmed: 30726801
doi: 10.1253/circj.CJ-18-1035
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

548-555

Auteurs

Nobuaki Tanaka (N)

Cardiovascular Center, Sakurabashi-Watanabe Hospital.

Koji Tanaka (K)

Cardiovascular Center, Sakurabashi-Watanabe Hospital.

Yuichi Ninomiya (Y)

Cardiovascular Center, Sakurabashi-Watanabe Hospital.

Yuko Hirao (Y)

Cardiovascular Center, Sakurabashi-Watanabe Hospital.

Takafumi Oka (T)

Cardiovascular Center, Sakurabashi-Watanabe Hospital.

Masato Okada (M)

Cardiovascular Center, Sakurabashi-Watanabe Hospital.

Hiroyuki Inoue (H)

Cardiovascular Center, Sakurabashi-Watanabe Hospital.

Ryo Nakamaru (R)

Cardiovascular Center, Sakurabashi-Watanabe Hospital.

Kohtaro Takayasu (K)

Cardiovascular Center, Sakurabashi-Watanabe Hospital.

Ryo Kitagaki (R)

Cardiovascular Center, Sakurabashi-Watanabe Hospital.

Yasushi Koyama (Y)

Cardiovascular Center, Sakurabashi-Watanabe Hospital.

Atsunori Okamura (A)

Cardiovascular Center, Sakurabashi-Watanabe Hospital.

Katsuomi Iwakura (K)

Cardiovascular Center, Sakurabashi-Watanabe Hospital.

Yasushi Sakata (Y)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine.

Kenshi Fujii (K)

Cardiovascular Center, Sakurabashi-Watanabe Hospital.

Koichi Inoue (K)

Cardiovascular Center, Sakurabashi-Watanabe Hospital.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH